Cited by 51Sexual function and dysfunction studiesUrological Disorders and TreatmentsUrinary Bladder and Prostate Research

Rationale for phosphodiesterase 5 inhibitor use post-radical prostatectomy: experimental and clinical review

Rambhatla, A, Kovanecz, I, Ferrini, M, Gonzalez-Cadavid, N F, Rajfer, J·2008·International Journal of Impotence Research

Abstract

Erectile dysfunction (ED) is a common complication after radical prostatectomy and results from trauma sustained by the cavernosal nerves. This is a major concern for patients and often affects treatment decisions. The likely mechanism for post-prostatectomy ED is through corporal veno-occlusive dysfunction. There is an increasing amount of evidence to suggest that phosphodiesterase 5 inhibitors (PDE5 inhibitors), when given on a continuous long-term basis, can help to prevent and reverse ED after surgery. In this review article we will examine the pathophysiology of post-prostatectomy ED and discuss the experimental and available clinical evidence for administering PDE5 inhibitors after prostatectomy.

Integrity signals

Registry

Crossref · 10.1038/sj.ijir.3901588

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

2 of the 40 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Rambhatla, A., Kovanecz, I., Ferrini, M., Gonzalez-Cadavid, N. F., & Rajfer, J.
Affiliations
  • Harbor–UCLA Medical Center (US)
  • The Lundquist Institute (US)
  • University of California, Los Angeles (US)
Corresponding author
Rajfer, J
Venue
International Journal of Impotence Research
Published
2007-08-02
Volume
20
Issue
1
Pages
30-34
ISSN
  • 0955-9930 (ISSN-L)
  • 1476-5489
OpenAlex
W2158072358
Cited by
51
References
40
Citations by year
2025: 1 · 2022: 1 · 2021: 1 · 2018: 2 · 2017: 1 · 2016: 1 · 2015: 4 · 2014: 5 · 2013: 2 · 2012: 2
FWCI
0.89
Type
journal article
Language
en
Open access
closed
Locations
  • International Journal of Impotence Research (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
  • Health Sciences › Medicine › Urology › Urological Disorders and Treatments
  • Health Sciences › Medicine › Urology › Urinary Bladder and Prostate Research
Keywords
phosphodiesterase-5 inhibitors, erectile dysfunction, radical prostatectomy, post-prostatectomy erectile dysfunction
MeSH terms
Humans, Erectile Dysfunction, Male, Penile Erection, Penis, Phosphodiesterase Inhibitors, Prostatectomy, Treatment Outcome, Cyclic Nucleotide Phosphodiesterases, Type 5

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review